Abstract:Oral mucosal drug delivery is an alternative method of systemic drug delivery that offers several advantages over both injectable and enteral methods. Because the oral mucosa is highly vascularised, drugs that are absorbed through the oral mucosa directly enter the systemic circulation, bypassing the gastrointestinal tract and first-pass metabolism in the liver. For some drugs, this results in rapid onset of action via a more comfortable and convenient delivery route than the intravenous route. Not all drugs, however, can be administered through the oral mucosa because of the characteristics of the oral mucosa and the physicochemical properties of the drug. Several cardiovascular drugs administered transmucosally have been studied extensively. Nitroglycerin is one of the most common drugs delivered through the oral mucosa. Research on other cardiovascular drugs, such as captopril, verapamil and propafenone, has proven promising. Oral transmucosal delivery of analgesics has received considerable attention. Oral transmucosal fentanyl is designed to deliver rapid analgesia for breakthrough pain, providing patients with a noninvasive, easy to use and nonintimidating option. For analgesics that are used to treat mild to moderate pain, rapid onset has relatively little benefit and oral mucosal delivery is a poor option. Oral mucosal delivery of sedatives such as midazolam, triazolam and etomidate has shown favourable results with clinical advantages over other routes of administration. Oral mucosal delivery of the antinausea drugs scopolamine and prochlorperazine has received some attention, as has oral mucosal delivery of drugs for erectile dysfunction. Oral transmucosal formulations of testosterone and estrogen have been developed. In clinical studies, sublingual testosterone has been shown to result in increases in lean muscle mass and muscle strength, improvement in positive mood parameters, and increases in genital responsiveness in women. Short-term administration of estrogen to menopausal women with cardiovascular disease has been shown to produce coronary and peripheral vasodilation, reduction of vascular resistance and improvement in endothelial function. Studies of sublingual administration of estrogen are needed to clarify the most beneficial regimen. Although many drugs have been evaluated for oral transmucosal delivery, few are commercially available. The clinical need for oral transmucosal delivery of a drug must be high enough to offset the high costs associated with developing this type of product. Drugs considered for oral transmucosal delivery are limited to existing products, and until there is a change in the selection and development process for new drugs, candidates for oral transmucosal delivery will be limited.

Study on New Method of Delivering Drug on Rectum Mucous Membrane

Effect of Different Electrical Parameters on Rectum Mucous Membrane Delivery of Gardenia Jasminoides Ellis Extract Using Eletroporation

Study on Percutaneous Permeability of Cinnamon Extract in β-Cyclodextrin Composite Ethosomes

Study on Percutaneous Permeation of Naloxone Ethosomes Gel Complex

[Study on in vitro mucosal permeation properties and factors affecting mucosal permeability of paeonol]

Betaine-Based and Polyguanidine-Inserted Zwitterionic Micelle as a Promising Platform to Conquer the Intestinal Mucosal Barrier

Evaluation of intestinal absorption of ginsenoside Rg1 incorporated in microemulison using parallel artificial membrane permeability assay.

Preparation and evaluation of in situ temperature-controlled heating gel loaded with compound Sophora flavescens decoction for rectal delivery

Study on preparation and transdermal drug delivery of saponins of panax notoginseng compound liposomal gel

Glu‐derived zwitterionic micelles with conquering the intestinal mucosal barrier toward oral delivery

Enema ion compositions for enhancing colorectal drug delivery

Transbuccal delivery of 2',3'-dideoxycytidine: in vitro permeation study and histological investigation.

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

Transdermal delivery of piroxicam by surfactant enhanced electroporation

Efficiency of a novel thermosensitive enema in situ hydrogel carrying Periplaneta americana extracts for the treatment of ulcerative colitis

Comparative Enhancing Effects of Electret with Chemical Enhancers on Transdermal Delivery of Meloxicam in Vitro

Transdermal Drug Delivery by Electroporation: the Effects of Surfactants on Pathway Lifetime and Drug Transport

Effects of Different Penetration Enhancers on the Kinetics Character of Permeability of Glimepiride Through Rabbit Skin in Vitro

Influence on Intestinal Mucous Permeation of Paclitaxel of Absorption Enhancers and Dosage Forms Based on Electron Spin Resonance Spectroscopy

Study on preparation and percutaneous absorption in vitro of piroxicam microemulsion

Studies on absorption of fentanyl across buccal mucosa